Physician profile
Monica J Decicco
NPI 1659426864
$2,853.73
in general payments reported to CMS, 2019-2025
21 companies · $746 in 2025
The $746 reported for 2025 was more than what 93% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $184 · 2022: $485 · 2023: $795 · 2024: $644 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,100 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,099.55 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.78 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $358.42 | 2023-2025 | Myfembree, Gemtesa |
| Organon LLC | $265.15 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $257.78 | 2021-2024 | Twirla |
| Pfizer INC. | $233.93 | 2022-2024 | |
| Astellas Pharma US INC | $226.62 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $188.59 | 2022-2025 | Slynd |
| Millicent US INC | $184.91 | 2025 | Femlyv, Intrarosa |
| Myovant Sciences INC. | $129.46 | 2022 | |
| Mayne Pharma Commercial LLC | $114.31 | 2025 | |
| Shield Therapeutics INC | $88.75 | 2023-2024 | Accrufer |
| Biogen, INC. | $76.75 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $68.45 | 2022-2024 | Aptima |
| Pacira Pharmaceuticals Incorporated | $50.10 | 2025 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $45.35 | 2024-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $44.37 | 2024 | Tisseel |
| Coopersurgical, INC. | $34.64 | 2025 | Paragard T 380a |
| Scynexis, INC. | $30.26 | 2022 | |
| Avion Pharmaceuticals | $23.80 | 2023 | Balcoltra |
| Convatec INC. | $18.78 | 2023 | |
| Evofem Biosciences, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Decicco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.